Kenvue (KVUE) gains over 17% fresh off their NYSE debut. Jenny Horne discusses this as KVUE is the consumer health business spin off of Johnson & Johnson (JNJ). KVUE started trading at $25.35, which is up 16% from the IPO price. She talks about how JNJ owns 1.72B KVUE shares. Tune in to find out more about the stock market today.
04 May 2023
Market On Close
08 May 2023
Market On Close
31 Mar 2023
Next Gen Investing
20 Mar 2023
Next Gen Investing
25 May 2023
Next Gen Investing
13 Apr 2023
Next Gen Investing
18 Apr 2023